Dementia [15], including Alzheimer’s disease and vascular dementia, can be detected by objective measures of cognitive impairment and biomarkers, such as β-amyloid (1–42), total tau, and phospho-tau-181 in cerebrospinal fluid [16]. This evidence concerns the gene MAPT and Cognitive impairment.